Morningside Venture Investments Ltd - 15 Aug 2023 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Reporting relationship: 10%+ Owner
Issuer ticker: AMLX
Reported as of: 15 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Aug 2023, 17:34:18 UTC
Prior SEC filing: 25 Jul 2023
Next SEC filing: 30 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Frances Anne Elizabeth Richard, Director

Key filing fact

Morningside Venture Investments Ltd filed Form 4 for Amylyx Pharmaceuticals, Inc. (AMLX) on 17 Aug 2023.

Key facts

This page summarizes Morningside Venture Investments Ltd's Form 4 filing for Amylyx Pharmaceuticals, Inc. (AMLX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2023, 17:34.

Change

Previous filing in this sequence was filed on 25 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMLX transaction

Common Stock

Gift

Transaction value: $0
Shares: -2,000,000
Change %: -29%
Price: $0.000000
Shares after: 4,997,302
Date: 15 Aug 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Morningside Venture Investments Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

Footnote F2

Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.